Stock Earnings

Question 1

Báo cáo tài chính chính của JCR Pharmaceuticals Co Ltd là gì?

Accepted Answer

Theo báo cáo tài chính mới nhất (Form-10K), JCR Pharmaceuticals Co Ltd có tổng tài sản là $104,855, lợi nhuận ròng loss là $-4,759

Question 2

Tỷ lệ tài chính chính của JCRRF là gì?

Accepted Answer

Tỷ lệ thanh khoản của JCR Pharmaceuticals Co Ltd là 1.81, tỷ suất lợi nhuận ròng là -14.38, doanh thu trên mỗi cổ phiếu là $267.08.

Question 3

Doanh thu của JCR Pharmaceuticals Co Ltd được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?

Accepted Answer

JCR Pharmaceuticals Co Ltd largest revenue segment is Pharmaceutical, at a revenue of 33,072,000,000 in the most earnings release.For geography, Japan is the primary market for JCR Pharmaceuticals Co Ltd, at a revenue of 33,072,000,000.

Question 4

JCR Pharmaceuticals Co Ltd có lợi nhuận không?

Accepted Answer

no, theo báo cáo tài chính mới nhất, JCR Pharmaceuticals Co Ltd có lợi nhuận ròng loss là $-4,759

Question 5

JCR Pharmaceuticals Co Ltd có nợ không?

Accepted Answer

yes, JCR Pharmaceuticals Co Ltd có nợ là 57,812

Question 6

JCR Pharmaceuticals Co Ltd có bao nhiêu cổ phiếu đang lưu hành?

Accepted Answer

JCR Pharmaceuticals Co Ltd có tổng cộng 121.83 cổ phiếu đang lưu hành

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	37,777	33,072	42,871	34,343	51,082	30,085
Revenue Growth (YoY)	7%	-23%	25%	-33%	70%	21%
Cost of Revenue	11,326	11,333	11,620	8,886	10,461	7,812
Gross Profit	26,451	21,739	31,251	25,457	40,621	22,273
Selling, General & Admin	29,982	12,958	12,485	11,678	13,511	8,643
Research & Development	--	15,431	11,234	8,802	7,175	5,360
Operating Expenses	30,153	28,580	23,720	20,482	20,688	14,004
Other Non Operating Income (Expenses)	90	35	5	59	38	23
Pretax Income	-3,317	-6,414	7,244	5,412	19,404	8,653
Income Tax Expense	-1,009	-1,718	1,707	1,625	4,886	1,764
Net Income	-2,358	-4,759	5,507	3,772	14,507	6,892
Net Income Growth	440%	-186%	46%	-74%	110%	157%
Shares Outstanding (Diluted)	121.95	123.82	125.39	124.83	124.2	124.13
Shares Change (YoY)	-3%	-1%	0%	1%	0%	0%
EPS (Diluted)	-19.32	-38.43	43.91	30.21	116.79	55.52
EPS Growth	453%	-188%	45%	-74%	110%	157%
Free Cash Flow	-9,859	-15,373	7,217	-14,059	-2,044	2,813
Free Cash Flow Per Share	-80.83	-124.15	57.55	-112.61	-16.45	22.66
Gross Margin	70.01%	65.73%	72.89%	74.12%	79.52%	74.03%
Operating Margin	-9.79%	-20.68%	17.56%	14.48%	39.02%	27.48%
Profit Margin	-6.24%	-14.38%	12.84%	10.98%	28.39%	22.9%
Free Cash Flow Margin	-26.09%	-46.48%	16.83%	-40.93%	-4%	9.35%
EBITDA	-536	-3,467	10,728	6,972	21,878	10,161
EBITDA Margin	-1.41%	-10.48%	25.02%	20.3%	42.82%	33.77%
D&A For EBITDA	3,166	3,374	3,197	1,997	1,945	1,892
EBIT	-3,702	-6,841	7,531	4,975	19,933	8,269
EBIT Margin	-9.79%	-20.68%	17.56%	14.48%	39.02%	27.48%
Effective Tax Rate	30.41%	26.78%	23.56%	30.02%	25.18%	20.38%

JCR Pharmaceuticals Co Ltd (JCRRF) Price

JCRRF Stock Price Chart

JCRRF Income

Follow-Up Questions